This inventor holds 1 USPTO granted patent. Top assignee: Human Engineering Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Akane Minagawa: Innovator in Melanonychia Diagnosis
Introduction: Akane Minagawa is a prominent inventor based in Nagano, Japan. She has made significant contributions to the field of medical technology, particularly in the diagnosis of melanonychia. Her innovative approach combines digital imaging and data analysis to improve patient outcomes.
Latest Patents: Akane Minagawa holds a patent for a determination device, determination method, and program. This device includes an acquisition unit that acquires digital color image data of a region of interest in melanonychia of a subject. It also features a calculation unit that calculates an indicator value from variation in RGB values of each pixel of the digital color image data. The output unit then determines whether the melanonychia is malignant or benign based on the calculated indicator value compared to a threshold value. This patent represents a significant advancement in non-invasive diagnostic methods.
Career Highlights: Throughout her career, Akane has demonstrated a commitment to innovation in healthcare technology. Her work at Human Engineering Co., Ltd. has positioned her as a leader in the development of diagnostic tools that enhance the accuracy of medical assessments.
Collaborations: Akane collaborates with talented professionals in her field, including Takayuki Sota and Hiroshi Ikeda. Their combined expertise fosters a creative environment that drives innovation and improves healthcare solutions.
Conclusion: Akane Minagawa's contributions to the field of medical technology, particularly through her patent for a determination device, highlight her role as an influential inventor. Her work continues to pave the way for advancements in the diagnosis of melanonychia, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile